Securities and Exchange Commission filings indicate that Oxford Finance LLC acquired 1.62 million common shares, representing 16.5% ownership in the clinical-stage company. Oxford Finance, the ...
KALA BIO Inc. (NASDAQ: KALA) jumped 37.87% to $0.88 in after-hours trading on Tuesday. Check out the current price of KALA stock here. According to Benzinga Pro data, the stock closed the regular ...
East Hawaiʻi Cultural Center’s bronze gong orchestra has returned from a two-week study tour to Surakarta in Central Java, Indonesia, fortified with new musical skills and brimming with stories about ...
ARLINGTON, Mass. (AP) — ARLINGTON, Mass. (AP) — KALA BIO, Inc. (KALA) on Wednesday reported a loss of $7.6 million in its third quarter. On a per-share basis, the Arlington, Massachusetts-based ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Arlington biotech Kala Bio has ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Kala Pharmaceuticals ...
Kala Bio said it laid off most of its employees after receiving notice that its lender, Oxford Finance, intends to foreclose on all of its remaining assets. The move follows the biotech company's ...
Borobudur is one of the great monuments of Southeast Asia. It is a colossal Buddhist stupa that rises out of the rice paddies and palm trees with the nearby volcano Gunung Merapi in the distance. This ...
An Indonesian border security soldier from Task Force Yonif 312/Kala Hitam stands guard during a free health check-up program in Bupul Village, Elikobel District, Merauke Regency, South Papua, on ...
Shares of KALA BIO KALA have nosedived 88.3% in a month after the company announced the failure of a mid-stage study evaluating its only clinical pipeline candidate, KPI-012, for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results